Johns Hopkins Medicine researchers are publishing their findings of a study at the Journal of Analytical Toxicology this week that will address the question of whether the use of CBD products has a significant impact on drug testing for cannabis. Current urine drug testing for cannabis targets THCCOOH, which can be found in hemp-derived CBD products. According to Tory Spindle, Ph.D., a researcher in the Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center, “pure CBD did not produce a positive result on a standard urine drug test for cannabis. However, 2 of 6 participants tested positive for cannabis after they inhaled CBD-dominant cannabis vapor.”
